Stay updated on Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page.

Latest updates to the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 was added to the history and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedAdded Revision: v3.4.2. Removed the outdated funding notice and the Revision: v3.4.1 reference from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedThe history now includes a site-wide funding notice and a revision update to v3.4.1, replacing the former v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedThe history now shows a glossary toggle, color-coded change highlights (green for additions and red for deletions), and a new revision tag v3.4.0. The previous revision tag v3.3.4 is removed.SummaryDifference0.4%

- Check63 days agoChange DetectedThe footer now displays Revision: v3.3.4 and no longer shows Revision: v3.3.3.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded Revision: v3.3.3 to the revision history. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.1%

Stay in the know with updates to Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page.